Clinical Trials Directory

Trials / Unknown

UnknownNCT03061162

Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis

Phase II Study of Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Yang Yang · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This phase II trial studies the side effects and response of pulsed low dose rate radiation therapy in treating gastric cancer patients with peritoneal metastasis.

Detailed description

This phase II trial studies the side effects and response of pulsed low dose rate radiation therapy in treating gastric cancer patients with peritoneal metastasis. Radiation therapy uses pulsed low dose rate high energy X rays to kill tumor cells and make less side effects than conventional 3-dimensional conformal radiation therapy. Palliative radiation therapy may help gastric cancer patients with peritoneal metastasis live more comfortably.

Conditions

Interventions

TypeNameDescription
RADIATIONpulsed low dose rate radiation therapyPulsed low dose rate 3-dimensional conformal radiation therapy

Timeline

Start date
2017-03-01
Primary completion
2020-03-01
Completion
2022-03-01
First posted
2017-02-23
Last updated
2017-06-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03061162. Inclusion in this directory is not an endorsement.

Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis (NCT03061162) · Clinical Trials Directory